MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients-Reference-Cited by-同舟云学术

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

Published:2022-03 Issue: Volume:Volume 15 Page:673-683
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Chen Xiaoman^ORCID,Zhou Jing,Wu Lili,Zhu Xiang,Deng Hong

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference40 articles.

1. Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B

2. World Health Organization. Global hepatitis report, 2017; 2017. Available from: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed April 2017.

3. Chinese national administration of disease prevention and control. Overview of the Chinese notifiable infectious diseases; 2018–2020. Available from: http://www.nhc.gov.cn/jkj/pgzdt/new_list.shtml. Accessed January 24, 2022.

4. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level

5. Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level;Heliyon;2024-06

2. The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis;Frontiers in Gastroenterology;2024-01-24

3. Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta‑analysis;Experimental and Therapeutic Medicine;2024-01-15

4. Survival of Patients with Hepatitis B-Related Hepatocellular Carcinoma with Concomitant Metabolic Associated Fatty Liver Disease;Diabetes, Metabolic Syndrome and Obesity;2023-08

5. Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality;Hepatology;2023-02-17